Used for analyzing different facets of blood clotting, laboratory instruments – coagulation analyzers – are set to witness a growth in demand between 2017 and 2025. These don’t just help in measuring prothrombin ratio, but are also used in various diagnostic and an analysis of developmental stages of various diseases. This is thus critical to figure source of bleeding or what is called thrombosis in patients.
Get Sample Copy of this Report @
As countries are investing in improving healthcare infrastructure, processes and thus outcomes, market for coagulation analyzer is witnessing a massive surge. Besides, rising incidence of chronic diseases, on a global level is also helping the market move on to a higher growth trajectory over the forecast period. As per a recent study, in the United States of America itself, six in every ten people are suffering from a chronic disease. And, four in every ten are suffering from at least two.
Over the last few years, both semi automatic and automatic variants of coagulations analyzers hit the market. This also led to need for clinical technicians to provide support alongside. Thus, it does not come as a surprise that over the forecast period, the global coagulation analyzer market is set to chart a significant, double digit CAGR (Compound Annual Growth Rate). Prominent end-users will be hospitals, self testing centers and clinical laboratories.
Check Table of Contents of this Report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=1202
Increase in geriatric population is also contributing to the growth of the global coagulation analyzer market. By 2050, one on six people worldwide will be in the 65 and above age group. And, some 2 billion people will occupy the age group of 60 and above in another 30 years. It is worth noting here that in the year 2015, there were just 900 million people occupying this age group. The ratio of people aged 65 and above to the total population will be 1:4 by 2050.